Myalgic Encephalomyelitis / Chronic Fatigue Syndrome — Research Summary
Printed from RareWays (rareways.com.au) on 10 September 2026
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Non-invasive electrochemical detection of cortisol in artificial sweat using molecularly imprinted polymer.
Ayankojo Akinrinade George et al. — Talanta (1 September 2026)
https://pubmed.ncbi.nlm.nih.gov/41967225/
- 2.
Exploring differences in protein cargo of extracellular vesicles from ME/CFS patient plasma compared to healthy controls.
Rydland Anne et al. — Biochemistry and biophysics reports (1 September 2026)
https://pubmed.ncbi.nlm.nih.gov/42375682/
- 3.
Shengyang Sanhuo decoction and its disassembled prescriptions improve chronic fatigue syndrome in mice: Insights from lipid metabolism and autophagy.
Li Lingling et al. — Journal of ethnopharmacology (10 August 2026)
https://pubmed.ncbi.nlm.nih.gov/42000004/
- 4.
Pipeline-optimized machine learning for chronic fatigue syndrome diagnosis: A lightweight, interpretable model using blood biochemical and metabolomic data.
Li Junrong et al. — Computational biology and chemistry (1 August 2026)
https://pubmed.ncbi.nlm.nih.gov/41791269/
- 5.
The efficacy of exercise in patients with myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and meta-analysis.
Zhao Liping et al. — Journal of psychosomatic research (1 August 2026)
https://pubmed.ncbi.nlm.nih.gov/42000527/
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome is a complex, chronic disease characterised by profound fatigue that is not improved by rest, post-exertional malaise, and often cognitive impairment and sleep disturbances. It affects an estimated 240,000 Australians. The cause remains under investigation, with recent research identifying immune and neurological abnormalities.
Most Recent Research
Cortisol or its medicinal form hydrocortisone (HCT) in accessible biofluids is widely used as a biomarker of stress and stress-related disorders, including Cushing syndrome, chronic fatigue syndrome, post-traumatic stress disorders, and fibromyalgia. Here, we report a simple nanomaterial-free electrochemical sensing strategy for selective cortisol detection based on a molecularly imprinted polymer (MIP) formed directly on indium tin oxide (ITO). The resulting sensor exhibited a wide linear dynamic range (100 pg/mL to 160 ng/mL) in artificial sweat, covering clinically relevant cortisol concentrations. Detection limits of 2.2 pg/mL and 8.2 ng/mL in phosphate-buffered saline (PBS) and artificial sweat respectively, were achieved. Sensor's selectivity was validated against structurally related steroid hormones (cortisone, progesterone, estradiol, and testosterone) and other interferents of comparable molecular weight. The sensor also demonstrated strong initial operational stability and reusability over at least nine rebinding/regeneration cycles with minimal performance drift (RSD <5%). Thus, despite the exclusion of signal amplifying nanomaterial in the sensor preparation, an analytical platform with high performance was achieved through intelligent molecular design. This approach is readily transferrable to other electrode architectures that support more flexible and wearable cortisol monitoring in non-invasive biofluids for clinical and well-being applications.
Common Questions
What is Myalgic Encephalomyelitis / Chronic Fatigue Syndrome?
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome is a complex, chronic disease characterised by profound fatigue that is not improved by rest, post-exertional malaise, and often cognitive impairment and sleep disturbances. It affects an estimated 240,000 Australians. The cause remains under investigation, with recent research identifying immune and neurological abnormalities.
How many clinical trials are available for Myalgic Encephalomyelitis / Chronic Fatigue Syndrome?
RareWays currently indexes 223 clinical trials for Myalgic Encephalomyelitis / Chronic Fatigue Syndrome, of which 40 are actively recruiting. Trial availability changes as new studies are registered — check the trials tab for current status.
Where does the research data for Myalgic Encephalomyelitis / Chronic Fatigue Syndrome come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Myalgic Encephalomyelitis / Chronic Fatigue Syndrome.
No spam. Unsubscribe any time. Not medical advice.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.